Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Simon Property Group
SPG
$74.5B
| $44.4M | 0.03% |
275,960
+11,813
| +4% | +$1.89M |
|
|
GBT
552
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $44M | 0.03% |
1,415,558
+431,325
| +44% | +$12.1M |
|
553
Centene
CNC
$31.3B
| $43.9M | 0.03% |
908,130
+702,390
| +341% | +$30.2M |
|
554
State Street
STT
$50.9B
| $43.9M | 0.03% |
459,638
-84,269
| -15% | -$7.85M |
|
|
PLYA
555
DELISTED
Playa Hotels & Resorts
PLYA
| $43.7M | 0.03% |
4,186,994
+79,431
| +2% | +$897K |
|
556
Bath & Body Works
BBWI
$4.01B
| $43.7M | 0.03% |
1,297,719
-808,909
| -38% | -$27.2M |
|
|
SCG
557
DELISTED
Scana
SCG
| $43.4M | 0.03% |
894,923
-355,473
| -28% | -$21.8M |
|
|
DOC
558
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $43.3M | 0.03% |
2,444,157
-349,211
| -13% | -$6.44M |
|
559
CTS Corp
CTS
$1.72B
| $42.9M | 0.03% |
1,779,817
-7,704
| -0.4% | -$173K |
|
|
CSW
560
CSW Industrials
CSW
$4.71B
| $42.8M | 0.03% |
964,571
+66,815
| +7% | +$2.71M |
|
561
Ulta Beauty
ULTA
$20.4B
| $42.7M | 0.03% |
188,865
+73,103
| +63% | +$17.6M |
|
562
Zions Bancorporation
ZION
$10.1B
| $42.6M | 0.03% |
902,037
-329,034
| -27% | -$14.6M |
|
563
Danaher
DHR
$135B
| $41.7M | 0.03% |
548,951
-139,864
| -20% | -$10.4M |
|
564
First American
FAF
$7.67B
| $41.7M | 0.03% |
833,757
-21,706
| -3% | -$1.04M |
|
565
Huntington Ingalls Industries
HII
$11.3B
| $41.6M | 0.03% |
183,934
-138,000
| -43% | -$28.8M |
|
566
HCA Healthcare
HCA
$84.8B
| $41.6M | 0.03% |
523,063
+175,158
| +50% | +$14.1M |
|
567
JB Hunt Transport Services
JBHT
$27.1B
| $41.6M | 0.03% |
374,762
-251,760
| -40% | -$24.4M |
|
568
Omnicell
OMCL
$1.86B
| $41.3M | 0.03% |
809,086
-422,847
| -34% | -$20.3M |
|
|
USCR
569
DELISTED
U S Concrete, Inc.
USCR
| $41M | 0.03% |
537,823
-26,738
| -5% | -$2.05M |
|
570
Heartland Express
HTLD
$1.11B
| $40.9M | 0.03% |
1,629,634
-380,308
| -19% | -$8.28M |
|
571
First Horizon
FHN
$12.1B
| $40.8M | 0.03% |
2,131,536
+1,877,196
| +738% | +$32.9M |
|
572
News Corp Class A
NWSA
$14.5B
| $40.6M | 0.03% |
3,064,626
-4,423,436
| -59% | -$59.8M |
|
573
Cytokinetics
CYTK
$11B
| $40.3M | 0.03% |
2,778,605
+93,675
| +3% | +$1.28M |
|
574
Cigna
CI
$76.6B
| $40.3M | 0.03% |
215,424
+104,596
| +94% | +$18.6M |
|
|
UMPQ
575
DELISTED
Umpqua Holdings Corp
UMPQ
| $39.7M | 0.03% |
2,036,099
-66,623
| -3% | -$1.21M |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.